Bill Text: IL HB2695 | 2009-2010 | 96th General Assembly | Introduced

---

Bill Title: Amends the Illinois Public Aid Code. Provides that the Department of Healthcare and Family Services shall contract with a third-party nongovernmental entity to administer components of the medical assistance program, including, but not limited to, payment of medical claims, negotiations with medical providers in determining reimbursement rates, negotiations with drug manufacturers in relation to drug manufacturer rebates, and continued development of a preferred drug formulary.

Spectrum: Partisan Bill (Republican 1-0)

Status: (Introduced - Dead) 2010-12-08 - Assigned to Special Committee on Medicaid Reform [HB2695 Detail]

Download: Illinois-2009-HB2695-Introduced.html

---

96TH GENERAL ASSEMBLY State of Illinois 2009 and 2010 HB2695 Introduced 2/24/2009, by Rep. Patricia R. Bellock SYNOPSIS AS INTRODUCED:
305 ILCS 5/12-4.25d new
Amends the Illinois Public Aid Code. Provides that the Department of Healthcare and Family Services shall contract with a third-party nongovernmental entity to administer components of the medical assistance program, including, but not limited to, payment of medical claims, negotiations with medical providers in determining reimbursement rates, negotiations with drug manufacturers in relation to drug manufacturer rebates, and continued development of a preferred drug formulary.
LRB096 10539 DRJ 21362 b
FISCAL NOTE ACT MAY APPLY
A BILL FOR
HB2695 LRB096 10539 DRJ 21362 b
AN ACT concerning public aid.
Be it enacted by the People of the State of Illinois,
represented in the General Assembly:
Section 5. The Illinois Public Aid Code is amended by
adding Section 12-4.25d as follows:
(305 ILCS 5/12-4.25d new)
Sec. 12-4.25d. Administration of medical assistance
program. The Department of Healthcare and Family Services shall
contract with a third-party nongovernmental entity to
administer components of the medical assistance program under
Article V of this Code, including, but not limited to, payment
of medical claims, negotiations with medical providers in
determining reimbursement rates, negotiations with drug
manufacturers in relation to drug manufacturer rebates, and
continued development of a preferred drug formulary.